Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:38:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-24T16:48:29.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T16:36:20.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content with an access-denied page. This means users cannot view the trial details on that URL, and the site presents a generic error instead of the study information.
    Difference
    0.5%
    Check dated 2026-09-26T18:47:36.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 error and the trial content is no longer visible, changing how users access information about the INITIATE study.
    Difference
    18%
    Check dated 2026-09-19T17:45:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, signaling a minor update to the page version. This does not alter the study details or other visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:18:40.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.